Back to Authors

Howard, Diantha

Mayo Clinic

From the Larner College of Medicine at the University of Vermont (M.K.H., D.H., S.M.G.), Burlington; Duke University School of Medicine (L.D.H.-W.), Durham, NC; University of Miami Health System (M.B., M.A.F.), FL; University of Toronto School of Medicine

Citations 1

Rituximab as treatment for anti-MuSK myasthenia gravis

Neurology | August 11, 2017 | Volume: 89 | Issue: 10 | Pages: 1069-1077

10.1212/wnl.0000000000004341 | PMID 28801338